Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 10/10/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–10/09/2026 Record Record Date Vuga Group Change Status Recency Days Research Attention Score Pompe Pregnancy Sub-Registry 12/04/2007 OBSERVATIONAL not-comparable 6,885.75 0 Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing 12/14/2007 OBSERVATIONAL not-comparable 6,875.75 0 Investigating Mechanisms to Explain Age Associated Differences in Quality of Life Among Breast Cancer Patients 12/28/2007 OBSERVATIONAL not-comparable 6,861.75 0 Efficacy and Safety of 500mg of Fulvestrant 01/03/2008 INTERVENTIONAL not-comparable 6,855.75 0 Estrogen, Diet, Genetics and Endometrial Cancer 01/08/2008 OBSERVATIONAL not-comparable 6,850.75 0 Menstrual Cycle Maintenance and Quality of Life: A Prospective Study 01/10/2008 OBSERVATIONAL not-comparable 6,848.75 0 Carboplatin and Nab-Paclitaxel With or Without Vorinostat in Treating Women With Newly Diagnosed Operable Breast Cancer 02/15/2008 INTERVENTIONAL not-comparable 6,812.75 0 Levonorgestrel-Releasing Intrauterine System in Treating Patients With Complex Atypical Hyperplasia or Grade I Endometrial Cancer 11/11/2008 INTERVENTIONAL not-comparable 6,542.75 0 Longitudinal Evaluation of Women Undergoing Pelvic Surgery for the Treatment of Gynecologic Cancer 11/14/2008 OBSERVATIONAL not-comparable 6,539.75 0 Panther: A Study Comparing Biweekly and Tailored EC-T Versus Three Weekly FEC-T in Breast Cancer Patients 11/25/2008 INTERVENTIONAL not-comparable 6,528.75 0 Study of Women With Acute Coronary Syndromes and Nonobstructive Coronary Artery Disease 11/25/2008 INTERVENTIONAL not-comparable 6,528.75 0 Fish Oil Supplementation During Pregnancy for Prevention of Asthma, Eczema and Allergies in Childhood 11/26/2008 INTERVENTIONAL not-comparable 6,527.75 0 Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations 01/15/2009 OBSERVATIONAL not-comparable 6,477.75 0 Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women. 01/21/2009 OBSERVATIONAL not-comparable 6,471.75 0 Women's Ischemia Syndrome Evaluation (WISE) Coronary Vascular Dysfunction 01/30/2009 OBSERVATIONAL not-comparable 6,462.75 0 Vitamin D Supplementation During Pregnancy for Prevention of Asthma in Childhood 03/06/2009 INTERVENTIONAL not-comparable 6,427.75 0 Extended Follow Up of Young Women in Costa Rica Who Received Vaccine for Human Papillomavirus Types 16 and 18 and Unvaccinated Controls 03/23/2009 OBSERVATIONAL not-comparable 6,410.75 0 Collecting Tissue Samples for Future Research From Women Undergoing Surgery for Breast Cancer 05/12/2009 OBSERVATIONAL not-comparable 6,360.75 0 Collecting and Storing Tissue Samples From Women With or Without Breast Cancer 05/12/2009 OBSERVATIONAL not-comparable 6,360.75 0 Cervical Cancer Detection Using Optical Spectroscopy 05/13/2009 INTERVENTIONAL not-comparable 6,359.75 0 Study of Radiation Exposure and Bilateral Breast Cancer 05/18/2009 OBSERVATIONAL not-comparable 6,354.75 0 A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women With Inflammatory Bowel Disease 05/20/2009 OBSERVATIONAL not-comparable 6,352.75 0 Breast-Conserving Surgery and Whole-Breast Radiation Therapy With or Without Additional Radiation Therapy to the Tumor in Treating Women With Ductal Carcinoma in Situ (BONBIS) 05/25/2009 INTERVENTIONAL not-comparable 6,347.75 0 Radiation Therapy in Treating Women With Early Stage Breast Cancer 05/29/2009 INTERVENTIONAL not-comparable 6,343.75 0 Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism 06/26/2009 INTERVENTIONAL not-comparable 6,315.75 0 Aggressive Local Therapy for Limited Bone-Only Metastasis to Improve Progression-Free Survival in Breast Cancer Patients 06/26/2009 INTERVENTIONAL not-comparable 6,315.75 0 Intra-Pelvic Organ Motion for Cervix Cancer Patient Using Imaging 08/12/2009 OBSERVATIONAL not-comparable 6,268.75 0 Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer 09/15/2009 INTERVENTIONAL not-comparable 6,234.75 0 Lymphedema Following Hand/Wrist Surgery in Women Post Axillary Node Dissection 09/25/2009 INTERVENTIONAL not-comparable 6,224.75 0 A Multi Modality Surveillance Program for Women At High Risk for Breast Cancer 10/05/2009 OBSERVATIONAL not-comparable 6,214.75 0 Study of Changes in Skeletal Muscle After Caloric Restriction 10/12/2009 OBSERVATIONAL not-comparable 6,207.75 0 Extension Study of Lapatinib Plus Herceptin With or Without Endocrine Therapy 10/22/2009 INTERVENTIONAL not-comparable 6,197.75 0 Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer 10/23/2009 OBSERVATIONAL not-comparable 6,196.75 0 Motivational Interviewing for Physical Activity 11/06/2009 INTERVENTIONAL not-comparable 6,182.75 0 Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples 12/17/2009 OBSERVATIONAL not-comparable 6,141.75 0 Magnetic Resonance Imaging of Breast Cancer 12/18/2009 INTERVENTIONAL not-comparable 6,140.75 0 Colposcopy Versus HPV Testing to Identify Persistent Cervical Precancers 01/20/2010 INTERVENTIONAL not-comparable 6,107.75 0 Letrozole and RAD001 With Advanced or Recurrent Endometrial Cancer 02/12/2010 INTERVENTIONAL not-comparable 6,084.75 0 Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer 03/05/2010 INTERVENTIONAL not-comparable 6,063.75 0 Extending the National Health Service (NHS) Breast Screening Age Range 03/05/2010 INTERVENTIONAL not-comparable 6,063.75 0 Study to Compare the Efficacy and Safety of Olaparib When Given in Combination With Carboplatin and Paclitaxel, Compared With Carboplatin and Paclitaxel in Patients With Advanced Ovarian Cancer 03/05/2010 INTERVENTIONAL not-comparable 6,063.75 0 Positron Emission Tomography in Women With Advanced HER2-Positive Breast Cancer 03/26/2010 INTERVENTIONAL not-comparable 6,042.75 0 Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer 05/05/2010 INTERVENTIONAL not-comparable 6,002.75 0 Ethnic Differences in the Impact of Breast Cancer on Employment Status, Financial Situation, and Quality of Life 05/31/2010 OBSERVATIONAL not-comparable 5,976.75 0 Excision Followed by Radiofrequency Ablation for Breast Cancer 06/29/2010 INTERVENTIONAL not-comparable 5,947.75 0 Teriparatide (PTH) and Bone Strength in Postmenopausal Women 07/01/2010 OBSERVATIONAL not-comparable 5,945.75 0 Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer 07/22/2010 INTERVENTIONAL not-comparable 5,924.75 0 Predictive Assays In Cervix Cancer 08/13/2010 INTERVENTIONAL not-comparable 5,902.75 0 Rehabilitation of Cognitive Changes in Breast Cancer Survivors 08/16/2010 INTERVENTIONAL not-comparable 5,899.75 0 Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer Survivors 09/09/2010 INTERVENTIONAL not-comparable 5,875.75 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 10/10/2026 · upstream last modified 10/10/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Research Attention Score using the documented compute method. · methodology